Outlook Therapeutics at Eyecelerator @ AAO 2022

Sep 29, 2022


Panel: Defining Clinically Relevant Endpoints in Approval Trials
Time: 11:45 AM – 12:30 PM ET
Discussion Topic: Government, academic, and industry experts offer perspectives on benchmarking practices that accurately characterize the effectiveness of treatments in clinical studies and meet regulatory requirements.
Company Participant: Terry Dagnon, Chief Operations Officer

Company Presentation: Retina Showcases
Time: 2:46 PM – 2:51 PM ET
Presenter: Russ Trenary, President and Chief Executive Officer